LOADING
Comparing Eli Lilly and Company (LLY) and AbbVie Inc (ABBV), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | LLY | ABBV |
|---|---|---|
| Price | $1,255.40 | $264.96 |
| Change Today | +0.88% | +1.20% |
| Market Cap | -- | $468.2B |
| P/E Ratio | -- | 74.6 |
| Forward P/E | -- | 18.9 |
| PEG Ratio | -- | 0.43 |
| EPS | -- | $3.55 |
| Revenue Growth (YoY) | -- | 10.2% |
| Profit Margin | -- | 9.8% |
| Return on Equity | -- | 62.3% |
| Dividend Yield | -- | 2.61% |
| Beta | -- | 0.28 |
| 52-Week High | -- | $267.47 |
| 52-Week Low | -- | $189.40 |
| Volume | 2.5M | 5.2M |